U.S. prisons are experimenting with a high-priced monthly injection that could help addicted inmates stay off opioids after they are released, the Associated Press reports. Skeptics question its effectiveness and say the manufacturer has aggressively marketed an unproved drug to corrections officials. A single shot of Vivitrol, given in the buttocks, lasts for four weeks and . . .
Want to read more? Please subscribe to The Crime Report!